All Cancer Types
Study Name: Tempus Aries
- Cancer Stage: All
- Key Inclusion: Cohorts will change
- Description: A Biobank Registry Platform Study in Oncology: Participants with cancer will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.
- Study Number: Tempus Airies
- NCT#: NCT06207032